Kevin Caliendo
Stock Analyst at UBS
(4.33)
# 351
Out of 5,165 analysts
207
Total ratings
66.99%
Success rate
10.42%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $3.02 | +65.56% | 4 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Buy | $48 → $57 | $41.75 | +36.53% | 2 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $12 | $6.45 | +86.05% | 7 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $79 → $87 | $74.61 | +16.61% | 7 | Feb 25, 2026 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $210 | $198.94 | +5.56% | 17 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $169.45 | +9.18% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $11.73 | +36.40% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $25.02 | -0.08% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $17.51 | +19.93% | 9 | Jan 14, 2026 | |
| CVS CVS Health | Maintains: Buy | $96 → $97 | $75.84 | +27.90% | 11 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $77 → $79 | $67.14 | +17.66% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $380 → $415 | $345.88 | +19.98% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.22 | +80.18% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $920 → $980 | $943.25 | +3.90% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $217.59 | +1.11% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $285.49 | +50.62% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $266.85 | +19.92% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $146.49 | +16.05% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.63 | +59.86% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $268.35 | +45.33% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $169.99 | +47.07% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $34.76 | +127.27% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $292.07 | +96.87% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $243.19 | -25.98% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $5.39 | +1,235.81% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $29.46 | -62.66% | 4 | May 4, 2021 |
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $3.02
Upside: +65.56%
Medline
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $41.75
Upside: +36.53%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.45
Upside: +86.05%
Henry Schein
Feb 25, 2026
Maintains: Neutral
Price Target: $79 → $87
Current: $74.61
Upside: +16.61%
Quest Diagnostics
Feb 11, 2026
Maintains: Neutral
Price Target: $190 → $210
Current: $198.94
Upside: +5.56%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $169.45
Upside: +9.18%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $11.73
Upside: +36.40%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $25.02
Upside: -0.08%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $17.51
Upside: +19.93%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $75.84
Upside: +27.90%
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $67.14
Upside: +17.66%
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $345.88
Upside: +19.98%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.22
Upside: +80.18%
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $943.25
Upside: +3.90%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $217.59
Upside: +1.11%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $285.49
Upside: +50.62%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $266.85
Upside: +19.92%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $146.49
Upside: +16.05%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.63
Upside: +59.86%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $268.35
Upside: +45.33%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $169.99
Upside: +47.07%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $34.76
Upside: +127.27%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $292.07
Upside: +96.87%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $243.19
Upside: -25.98%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $5.39
Upside: +1,235.81%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $29.46
Upside: -62.66%